Stephen Wax

Stephen Wax is an accomplished clinical development professional with extensive experience in the biopharmaceutical industry. Currently serving as Vice President of Clinical Development at Cullinan Therapeutics since May 2024, Stephen previously held similar positions at Zenas BioPharma and Neurogastrx, Inc. Stephen's career includes significant roles at EMD Serono, Inc. as Senior Medical Director and Medical Director, as well as at Hoffmann-La Roche as CSS. Earlier in their career, Stephen worked as a Rheumatologist at Brigham and Women's Hospital. Stephen holds an MD and PhD in Rheumatology from the Icahn School of Medicine at Mount Sinai and has a foundational education from Cornell University.